سعر زيبراسيدل Ziprasidel‏ 40مجم 14 كبسولة 2026

Ziprasidel 40 mg 14 capsules by Delta Pharma, Egypt: ziprasidone 40 mg (atypical antipsychotic).

• Common (>=5% and at least twice placebo): schizophrenia - somnolence, respiratory tract infection; bipolar mania - somnolence, extrapyramidal symptoms, dizziness, akathisia, abnormal vision, asthenia, vomiting.International label, same formulation · DailyMed (US National Library of Medicine)

• Known history of QT prolongation, recent acute myocardial infarction, uncompensated heart failure, combination with other drugs that prolong the QT interval, known hypersensitivity to ziprasidone, and concomitant use of MAOIs or use within 14 days of stopping an MAOI.International label, same formulation · DailyMed (US National Library of Medicine)

• Boxed warning: elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death; ziprasidone is not approved for dementia-related psychosis.International label, same formulation · DailyMed (US National Library of Medicine)
• Dose-related QT/QTc prolongation and risk of sudden death; avoid with other QT-prolonging drugs, congenital long QT syndrome or history of cardiac arrhythmias. Other warnings include serotonin syndrome, neuroleptic malignant syndrome, severe cutaneous adverse reactions, tardive dyskinesia, metabolic changes, rash and orthostatic hypotension.International label, same formulation · DailyMed (US National Library of Medicine)

• Neonates exposed to antipsychotics during the third trimester are at risk of extrapyramidal and/or withdrawal symptoms after delivery. Published epidemiologic data have not established a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.International label, same formulation · DailyMed (US National Library of Medicine)
• Limited data indicate ziprasidone is present in human milk; consider the benefits of breastfeeding with the mother's clinical need and potential adverse effects (sedation, irritability, poor feeding, extrapyramidal symptoms reported with other atypical antipsychotics).International label, same formulation · DailyMed (US National Library of Medicine)